Skip to main content
Fig. 2 | Hereditas

Fig. 2

From: SLC3A2 inhibits ferroptosis in laryngeal carcinoma via mTOR pathway

Fig. 2

SLC3A2 is a key gene related to ferroptosis in laryngeal carcinoma. A Progression related DEGs were analyzed by KEGG-GO and enrichment. B Expression (p < 0.001) and prognosis (p < 0.045) of SLC3A2 between normal and tumor specimens in the database from TCGA. C RT-qPCR analysis the expression of SLC3A2 mRNA in normal (n = 30) and tumor (n = 30) specimens. D The expression of SLC3A2 protein in normal and tumor specimens was measured by western blotting. N: normal tissues. T: tumor tissues. n = 30. E IHC analysis of the expression of SLC3A2 in normal (n = 30) and tumor (n = 30) specimens. F&G The mRNA and protein expression of SLC3A2 in normal laryngeal epithelial cells and laryngeal carcinoma cells was measured by RT-qPCR and western blotting, respectively. Error bars represent data from three independent experiments (mean ± SD). *p < 0.05,**p < 0.01

Back to article page